Requires health insurance carriers to cover genetic testing after diagnosis of pancreatic cancer.
Take action
Record your position on this measure.
Create an account to record your position, submit testimony, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed Senate
- Passed General Assembly
- To Governor
- Became Law
Overview
This bill requires health insurance carriers in New Jersey to cover genetic testing for individuals diagnosed with pancreatic adenocarcinoma. It applies to various types of health insurance plans, including hospital service corporations, medical service corporations, and health benefits plans. The goal is to provide patients with access to genetic testing that can inform treatment decisions and management of the disease. The bill ensures that these tests are covered to the same extent as other medical conditions under the relevant insurance contracts.
Bill text
Read the latest version inline or switch to a previous version.
Document of record
- Version
- Introduced
- Published
- Not published in the source record
This version is published only as a document. Open the viewer to read it here, or download the file.
Sponsors
Official sponsors from legislative records.
2 on record
Primary sponsors
Joseph Vitale
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours